plantation; febrile neutropenic adult During the neutropenic period of hematopoietic cell transplantation (HCT) almost all patients have fever. However, it is only in some cases that an infectious origin for the febrile episode can be demonstrated. When blood cultures are negative, it is often not possible to establish the etiology of the infection. In these circumstances, an antifungal agent is often added empirically to the antibiotic regimen. Although such a strategy is often considered routine, the use of an antifungal agent would have been unwarranted with the attendant risks of toxicity, the potential induction of resistance and unnecessary cost in at least some cases.
C-reactive protein (CRP) is an easily quantifiable acutephase reactant in serum. In normal conditions CRP value is less than 1.0 mg/dl. 1 In immunocompetent patients, a value higher than 4 mg/dl is a sensitive marker of associated bacterial infection. Several studies in febrile patients suggest that CRP can be useful to differentiate bacterial from viral infection and fever of a noninfectious origin. Also, CRP can be used to differentiate between deep and superficial bacterial infections. [2] [3] [4] In febrile neutropenic children, a CRP value higher than 4 mg/dl is able to predict bacterial infection with a sensitivity of 100%. 5 Furthermore, serial determination of CRP is useful for monitoring the course of infection. Manian et al 6 obtained similar results in adult neutropenic patients. Schots et al 7, 8 described that in recipients of an allogeneic bone marrow transplantation, a CRP value higher than 10 mg/dl between days 6 and 10 after the progenitor cell infusion was an independent risk factor for the occurrence of major transplant-related events (infections, hepatic veno-occlusive disease, pneumonitis, severe endothelial leakage syndrome and acute graft-versus-host disease) and also for 100-day transplant-related mortality. However, the experience of Schots et al 7, 8 was that CRP measurement could neither identify the patients with fever secondary to a bacterial infection nor the patients with a fatal outcome of infectious origin during the neutropenic period.
The aim of the present study was: (1) to describe the changes in CRP values during the neutropenic period of HCT and (2) to study the usefulness of serial CRP determinations in the differential diagnosis and prognosis of febrile neutropenic episodes in adult patients receiving an HCT.
Patients and methods
Between April 2000 and March 2001, 100 consecutive patients who underwent HCT at our institution were included in the study. On admission, all patients had a double lumen jugular catheter inserted under radiological guidance. All patients received cyprofloxacin 500 mg twice a day p.o. from their admission until neutrophil recovery, and fluconazole 50 mg daily until þ 60 HCT as infection prophylaxis. On admission and every 28 days until discharge, patients received inhalated pentamidine as Pneumocystis carinii infection prophylaxis. Patients who were seropositive for herpesvirus simplex received 800 mg of oral aciclovir every 12 h until day þ 28 HCT. During the procedure, patients remained hospitalized in an isolation unit with laminar air flow protection.
As conditioning, patients undergoing allogeneic HCT received cyclophosphamide and either total body irradiation or busulfan. Patients undergoing autologous HCT received BEAC (BCNU, etoposide, cytosine arabinoside and cyclophosphamide) for non-Hodgkin's lymphoma and Hodgkin's disease, melphalan in case for multiple myeloma and cyclophosphamide and total body irradiation for acute leukemia. Neutropenia was defined as an absolute neutrophil count below 500/mm 3 . The measurement of CRP in the serum was carried out every 48 h from admission throughout the procedure until resolution of the febrile episode. The assesment of CRP was by nephelometry and was expressed in mg/dl (normal value 0.1 mg/dl).
When patients developed fever (axillary temperature X37.81C), blood cultures and culture of any relevant clinical material were obtained. A chest X-ray was performed and empirical broad-spectrum antibiotic treatment was started, with the activity active against P. aeruginosa. Treatment was modified according to microbiological results and clinical evolution. If fever persisted and cultures were negative after 5-7 days of antibiotics, empirical antifungal treatment with amphotericin B was started, after new samples for cultures had been taken.
The febrile episodes were classified as:
(1) Documented microbiological infection: bacterial if a pathogenic microorganism was isolated from a sterile sample or an opportunist microorganism (coagulasenegative Staphylococcus or Corynebacterium) in two consecutive blood cultures; fungal or viral infection, where a fungus was isolated from a sterile sample or serological tests were positive, antigens or DNA were detected. (2) Clinically documented infection, when a clinical focus existed. (3) Febrile episode of unidentified cause: when the patient could not be classified in any of the previous groups.
Statistical analysis was carried out by the program SPSS (version 9.0; SPSS, Inc., Chicago, IL, USA). Continuous variables were expressed as mean and standard deviation (s.d.) or median (range) according to their homogeneity. Categoric variables were compared using the w 2 test or the Fisher exact test (when necessary). The quantitative variables were compared by the Student-Fisher t-test.
A multivariate analysis was performed for the study of independent risk factors associated with mortality, obtaining the odds ratio (OR) and confidence interval 95% (CI 95%). Statistical significance was defined as a two-tailed P-value o0.05.
Results
In all, 100 patients were included in the study (male: 44; female: 56; median age: 44.5 years; range: 18-64 years). The HCT was autologous in 62 cases and allogeneic in 38. In all cases, the source of hematopoietic progenitors was peripheral blood. Primary hematological disease indications for transplant were: non-Hodgkin's lymphoma in 25 cases, multiple myeloma in 20 cases, acute leukemia 25, chronic myeloid leukemia 15 and other hematological diseases in 15 cases. On the day of admission, the mean CRP was 1.0 mg/ dl (s.d.: 0.8) and on day 0 (infusion day), 1.9 mg/dl (s.d. 1.5). There were no significant differences in CRP values with respect to hematological disease, conditioning employed or type of HCT.
All patients developed fever during the period of post-HCT neutropenia. The mean time to fever was 5.2 days (s.d.: 2.5) from the day of progenitor infusion. Documented microbiological infection was identified in 32 cases. The febrile episode was classified as clinically documented infection in 27 patients and as a febrile episode of unidentified cause in 41 cases. The mean CRP (s.d.) on the first day of fever was 8.5 (3.5), 10.1 (6.3) and 9.3 (5.2) mg/dl, respectively (P ¼ 0.2) ( Table 1) .
Of the 32 patients with documented infection, one had invasive aspergillosis and another cytomegalovirus infection. The other 30 had proven bacterial infections. The microorganisms isolated from blood cultures were Grampositive cocci in 23 patients and Gram-negative bacilli in seven cases. The mean CRP (s.d.) was 8.9 (3.6) and 7.1 (2.9) mg/dL, respectively (NS, Table 1 ).
On day 5 of antibiotic treatment, the afebrile patients (50 cases) had a mean CRP of 7.3 mg/dl (s.d.: 4.9), whereas the other 50 cases with persistent fever had a mean CRP of 10.8 mg/dl (s.d.: 6.8) (Po0.02). After modifications of antibiotic treatment and/or initiation of amphotericin B, 41 patients had a favorable evolution, and the other nine had persistent fever and died. The mean CRP (s.d.) on day 5 of antibiotic therapy of patients Table 1 CRP on first day of fever according to diagnosis who responded to changes in treatment was 9.5 mg/dl (6.2), and in the remaining nine with an unfavorable outcome it was 16.5 mg/dl (6.5), respectively (Po0.001).
Of the nine patients who died, death was directly attributed to infection in five, and in the other four it was due to another cause. The mean CRP (s.d.) was 21.0 mg/dl (4.4) in patients who died of an infection and 11 mg/dl (3.4) in patients who died from another cause (Po0.003), Table 2 . The characteristics of the nine patients who died are described in Table 3 . On univariate analysis, the variables related to death were HCT type (allogeneic 18%, autologous 3%, Po0.01), persistence of fever on the fifth day of antibiotic treatment (18 vs 0%, Po0.003), CRP value on the fifth day of empiric treatment (8 A CRP value on the fifth day of fever equal to or higher than 16 mg/dl was associated with death from infectious cause with a sensitivity of 100%, a specificity of 87%, a predictive positive and negative value of 30 and 100%, respectively.
Discussion
In our study, patients undergoing an HCT had initial CRP values that were slightly above normal (range: 0.5-5 mg/dl), probably relating to their underlying primary disease and the conditioning regimen used. When the patients became pyrexial post-HCT, the CRP level on the first day of fever was neither specific for bacterial infections nor was it of prognostic significance. In contrast, a CRP above 16 mg/dl on the fifth febrile day was strongly predictive of a poor outcome of infectious origin.
The population included in our study was adult patients who underwent an HCT. Prophylactic and conditioning regimens were systematically applied according to our protocol. The source of hematopoietic stem cells was peripheral blood in all cases. During neutropenia, patients remained hospitalized in an isolation unit with laminar air flow protection. Therefore, all the febrile neutropenic episodes evaluated were homogeneous for characteristics that could influence diagnosis and prognosis of an episode, whereas this was not the case in previous series.
In our experience, the CRP was elevated independently of the primary hematological disease at the time of transplant, type of HCT and conditioning regimen employed. Some authors have described that in advanced oncological diseases, the CRP value can be high and it drops after chemotherapy treatment. 9 However, the patients included in our study were in remission of their primary hematological disease or it was under control at the time of transplant.
The CRP level on the first day of fever, during the period of neutropenia, did not allow differentiation of the etiologies of the febrile episodes in our study. Santolaya et al 5 observed that a CRP value greater than 4 mg/dl in neutropenic febrile children was associated with bacterial infection with a sensitivity of 100%. Furthermore, serial determination of CRP was useful for monitoring the course of infection. Manian et al 6 obtained similar results in adults with neutropenic fever secondary to chemotherapy. In their patients, CRP levels greater than 20 mg/dl for five or more days were associated with a 50% mortality, in cases of adults patients with hemato-oncological diseases. Schots Table 2 CRP on first day of fever and fifth day of treatment according to outcome of febrile neutropenic episodes et al 7, 8 studied the predictive value of CRP in patients undergoing BMT. According to this author, a CRP value higher than 10 mg/dl between the sixth and 10th day after the infusion was an independent risk factor for major post-HCT complications including mortality.
Our study confirms the association between persistence of an elevated CRP value and an unfavorable outcome of any febrile infectious episode. Of note, of the nine patients who died, in five death was attributed to an infectious etiology (CRP on day 5 was of 21.0; s.d.: 4.4 mg/dl) and in the remaining four it was due to a noninfectious cause (11 s.d.: 3.4) (Po0.003). A CRP value equal to or higher than 16 mg/dl on the fifth day of fever identified a group of patients with an unfavorable outcome who died because of an infectious etiology with a sensitivity of 100%, a specificity of 87%, a predictive positive value of 30% and a negative predictive value of 100%.
This present study demonstrates that CRP monitoring during febrile neutropenic episodes in patients undergoing HCT helps to identify patients with a poorer outcome. In this population, all diagnostic and therapeutic efforts should be instigated promptly to improve their outcome.
